If the CgA level was slightly elevated, and the PSA level was between 10-20 ng/mL, Gleason score was 7, and clinical stage was T2b-T2c, it was classified as intermediate-risk prostate cancer. This evidence concerns the gene KLK3 and prostate cancer.